Neprilysin
Read More about this categoryShow Less
Neprilysin (NEP) is a type II membrane metalloendopeptidase composed of ∼750 residues with an active site containing a zinc-binding motif (HEXXH) at the extracellular carboxyl terminal domain. Neprilysin is capable of degrading the monomeric and the oligomeric forms of Aβ peptide. Neprilysin is the dominant Aβ peptide-degrading enzyme in the brain; Neprilysin becomes inactivated and down-regulated during both the early stages of Alzheimer’s disease (AD) and aging.
Neprilysin is a neutral endopeptidase and its inhibition increases bioavailability of natriuretic peptides, bradykinin, and substance P, resulting in natriuretic, vasodilatatory, and anti-proliferative effects.
Products Related to Neprilysin(12)
- GC10146AHU-377(Sacubitril)CAS: 149709-62-6Purity: >99.00%
AHU-377(Sacubitril) (AHU-377) is a potent and orally active NEP (neprilysin) inhibitor with an IC50 of 5 nM.
- GC16138AHU-377 hemicalcium saltCAS: 1369773-39-6Purity: >99.50%
AHU-377 hemicalcium salt (AHU-377 hemicalcium salt) is a potent NEP inhibitor with an IC50 of 5 nM.
- GC16768Phosphoramidon Disodium SaltCAS: 164204-38-0Purity: >98%
Phosphoramidon Disodium Salt is a metalloprotease inhibitor.
- GC30786Sacubitrilat (LBQ-657)CAS: 149709-44-4Purity: >98.00%
Sacubitrilat (LBQ-657) (Desethyl Sacubitril) is an active neprilysin (NEP) inhibitor.
- GC31583SQ28603 (SQ28,603)CAS: 100845-83-8Purity: >98%
SQ28603 (SQ28,603) is a potent and selective inhibitor of neutral endopeptidase 3.4.24.11 (NEP), an enzyme that degrades atrial natriuretic peptide (ANP).
- GC31608Candoxatril (UK 79300)CAS: 123122-55-4Purity: >98%
Candoxatril (UK 79300) is a neutral endopeptidase (NEP) inhibitor.
- GC38856TD-0212 TFACAS: 1073549-11-7Purity: >98.00%
TD-0212 TFA is an orally active dual pharmacology angiotensin II type 1 receptor (AT1) antagonist and neprilysin (NEP) inhibitor, with a pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10146 | AHU-377(Sacubitril) | 149709-62-6 | >99.00% | |
AHU-377(Sacubitril) (AHU-377) is a potent and orally active NEP (neprilysin) inhibitor with an IC50 of 5 nM. | ||||
| GC11784 | LCZ696 | 936623-90-4 | >99.50% | |
LCZ696, a combination of prodrug sacubitril and valsartan at equal molar ratios, is an oral active angiotensin II receptor-neprilysin inhibitor. | ||||
| GC16138 | AHU-377 hemicalcium salt | 1369773-39-6 | >99.50% | |
AHU-377 hemicalcium salt (AHU-377 hemicalcium salt) is a potent NEP inhibitor with an IC50 of 5 nM. | ||||
| GC16768 | Phosphoramidon Disodium Salt | 164204-38-0 | >98% | |
Phosphoramidon Disodium Salt is a metalloprotease inhibitor. | ||||
| GC17017 | Racecadotril | 81110-73-8 | >98.50% | |
Potent enkephalinase inhibitor | ||||
| GC30786 | Sacubitrilat (LBQ-657) | 149709-44-4 | >98.00% | |
Sacubitrilat (LBQ-657) (Desethyl Sacubitril) is an active neprilysin (NEP) inhibitor. | ||||
| GC31267 | NEP-In-1 | 465527-94-0 | >98% | |
NEP-IN-1 is a neutral endopeptidase (NEP) inhibitor with IC50 of 2 nM for dNEP. | ||||
| GC31583 | SQ28603 (SQ28,603) | 100845-83-8 | >98% | |
SQ28603 (SQ28,603) is a potent and selective inhibitor of neutral endopeptidase 3.4.24.11 (NEP), an enzyme that degrades atrial natriuretic peptide (ANP). | ||||
| GC31608 | Candoxatril (UK 79300) | 123122-55-4 | >98% | |
Candoxatril (UK 79300) is a neutral endopeptidase (NEP) inhibitor. | ||||
| GC32671 | NEP-IN-2 | 145775-14-0 | >98% | |
NEP-IN-2 is an inhibitor of neutral endopeptidase, used in the research of proliferation in atherosclerosis, restenosis. | ||||
| GC38856 | TD-0212 TFA | 1073549-11-7 | >98.00% | |
TD-0212 TFA is an orally active dual pharmacology angiotensin II type 1 receptor (AT1) antagonist and neprilysin (NEP) inhibitor, with a pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP. | ||||
| GC63732 | Sacubitril-13C4 hemicalcium salt | - | >98% | |
